Showing 401 - 420 results of 64,913 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( a ((fold decrease) OR (mean decrease)) ))', query time: 1.20s Refine Results
  1. 401

    GLB1 increases expression in HGPIN and a subset of PCa and correlates with decreased proliferation and increased expression of HP1γ. by Jennifer Wagner (523883)

    Published 2015
    “…Data are mean +/- 95% confidence intervals. * p<0.001. <b>(A)</b> Epithelial GLB1 expression is significantly increased in HGPIN and cancer compared to benign prostate in both nuclear and cytoplasmic compartments (All p<0.0001). …”
  2. 402
  3. 403
  4. 404
  5. 405
  6. 406
  7. 407
  8. 408
  9. 409

    Subset of selected genes showing a ≥2-fold change decrease of expression in the <i>furA</i>-turning off strain AGcoaRFurA. by Andrés González (767802)

    Published 2016
    “…<p>Subset of selected genes showing a ≥2-fold change decrease of expression in the <i>furA</i>-turning off strain AGcoaRFurA.…”
  10. 410
  11. 411
  12. 412

    Ageing results in an abrupt decrease in overall neurogenesis in the mouse DG. by Joana Gil-Mohapel (462002)

    Published 2013
    “…(C) An estimation of overall neurogenesis based on the total number of BrdU-positive cells that survived the 42-day period multiplied by the proportion of BrdU-positive cells that acquired a mature neuronal phenotype indicates an age-induced significant and abrupt decrease in the overall number of new neurons. *** <i>p</i> < 0.001 between 1.5 and 3 months and between 3 and 6 months. …”
  13. 413
  14. 414
  15. 415
  16. 416
  17. 417

    <i>roh</i> mutation results in Rh1 decrease. by Yu Huang (15093)

    Published 2015
    “…Scale bar, 50 μm. (B) Western blotting showing decreased Rh1 levels in the <i>roh</i><sup><i>EY04039</i></sup> mutant (<i>ey-flp Rh1</i>::<i>GFP; FRT42D roh</i><sup><i>EY04039</i></sup><i>/ FRT42D GMR-hid CL</i>); the INAD and TRP levels are not affected compared to the wild-type. …”
  18. 418
  19. 419
  20. 420

    Viability of microencapsulated FP ICCs decreased with time post-transplantation. by Vijayaganapathy Vaithilingam (390354)

    Published 2013
    “…B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p&lt;0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p&lt;0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”